Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1987 Jun;50(6):806–809. doi: 10.1136/jnnp.50.6.806

Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.

E K Perry, R H Perry, C J Smith, D J Dick, J M Candy, J A Edwardson, A Fairbairn, G Blessed
PMCID: PMC1032095  PMID: 2956364

Abstract

The status of cholinergic receptors in dementia is related to the question of potential cholinergic therapy. Whilst muscarinic receptor binding is generally reported to be normal or near normal, findings are reported which indicate substantial reductions of hippocampal nicotinic (high affinity nicotine) binding (occurring in conjunction with decreased choline acetyltransferase) in both Alzheimer's and Parkinson's but not Huntington's disease. A further indication that nicotinic receptor function may be abnormal in Alzheimer's disease is the extensive loss of an endogenous compound, detected for the first time in human brain, which inhibits normal nicotinic binding. Both receptor binding and the inhibitor are also substantially decreased with increasing age in the normal hippocampus.

Full text

PDF
806

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davies P., Feisullin S. Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain. Brain Res. 1981 Jul 20;216(2):449–454. doi: 10.1016/0006-8993(81)90148-7. [DOI] [PubMed] [Google Scholar]
  2. Davies P., Verth A. H. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains. Brain Res. 1977 Dec 16;138(2):385–392. doi: 10.1016/0006-8993(77)90758-2. [DOI] [PubMed] [Google Scholar]
  3. Lang W., Henke H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 1983 May 16;267(2):271–280. doi: 10.1016/0006-8993(83)90879-x. [DOI] [PubMed] [Google Scholar]
  4. Mash D. C., Flynn D. D., Potter L. T. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 1985 May 31;228(4703):1115–1117. doi: 10.1126/science.3992249. [DOI] [PubMed] [Google Scholar]
  5. Morrow A. L., Loy R., Creese I. Alteration of nicotinic cholinergic agonist binding sites in hippocampus after fimbria transection. Brain Res. 1985 May 20;334(2):309–314. doi: 10.1016/0006-8993(85)90223-9. [DOI] [PubMed] [Google Scholar]
  6. Perry E. K., Curtis M., Dick D. J., Candy J. M., Atack J. R., Bloxham C. A., Blessed G., Fairbairn A., Tomlinson B. E., Perry R. H. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1985 May;48(5):413–421. doi: 10.1136/jnnp.48.5.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Perry E. K. The cholinergic hypothesis--ten years on. Br Med Bull. 1986 Jan;42(1):63–69. doi: 10.1093/oxfordjournals.bmb.a072100. [DOI] [PubMed] [Google Scholar]
  8. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978 Nov 25;2(6150):1457–1459. doi: 10.1136/bmj.2.6150.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rosecrans J. A. Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. Eur J Pharmacol. 1971;14(1):29–37. doi: 10.1016/0014-2999(71)90119-1. [DOI] [PubMed] [Google Scholar]
  10. Schwartz R. D., Kellar K. J. In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem. 1985 Aug;45(2):427–433. doi: 10.1111/j.1471-4159.1985.tb04005.x. [DOI] [PubMed] [Google Scholar]
  11. Sershen H., Reith M. E., Hashim A., Lajtha A. Endogenous material in brain inhibiting [3H]nicotine and [3H]acetylcholine binding. J Neurosci Res. 1984;12(4):563–569. doi: 10.1002/jnr.490120405. [DOI] [PubMed] [Google Scholar]
  12. Shimohama S., Taniguchi T., Fujiwara M., Kameyama M. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia. J Neurochem. 1986 Jan;46(1):288–293. doi: 10.1111/j.1471-4159.1986.tb12960.x. [DOI] [PubMed] [Google Scholar]
  13. White P., Hiley C. R., Goodhardt M. J., Carrasco L. H., Keet J. P., Williams I. E., Bowen D. M. Neocortical cholinergic neurons in elderly people. Lancet. 1977 Mar 26;1(8013):668–671. doi: 10.1016/s0140-6736(77)92114-6. [DOI] [PubMed] [Google Scholar]
  14. Whitehouse P. J., Martino A. M., Antuono P. G., Lowenstein P. R., Coyle J. T., Price D. L., Kellar K. J. Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res. 1986 Apr 16;371(1):146–151. doi: 10.1016/0006-8993(86)90819-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES